ACT’s Lisa Henderson interviews John Potthoff, PhD, CEO of Elligo Health Research, about decentralizing and restarting clinical trials amid the COVID-19 pandemic.
Sponsored Videos
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Targeted and Strategy-Driven Clinical Development
3
ACT Brief: FDA’s Agentic AI Rollout, Exercise Interventions for Long COVID, and Patient-Centered Evidence Beyond the Trial
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
